No causal effects between rosiglitazone and cardiovascular disease or risk factors: a Mendelian randomization study

CONCLUSIONS: The findings from this MR study indicate no causal relationship between rosiglitazone and CVDs or risk factors. Hence, previous observational studies may have been biased.PMID:37318502 | DOI:10.26355/eurrev_202306_32647

Source: Pharmacological Reviews - June 15, 2023 Category: Drugs & Pharmacology Authors: X-M Li Z-J Wu Z-L Xu A Li M-Q Liu C-G Song K Wu Source Type: research